1038. In Vitro Activity of Tebipenem, an Orally Available Carbapenem Agent, Against a Collection of Surveillance Gram-Positive Clinical Isolates

BACKGROUND: Tebipenem, an orally bioavailable carbapenem administered as a pro-drug, completed a phase 3 clinical trial for evaluating its safety and efficacy for the treatment of complicated urinary tract infection and acute pyelonephritis. The purpose of this study was to investigate the in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales: Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644704/
http://dx.doi.org/10.1093/ofid/ofab466.1232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644704/
http://dx.doi.org/10.1093/ofid/ofab466.1232

Ejemplares similares